Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland. (2023). Swiss Medical Weekly, 153(1), 40039. https://doi.org/10.57187/smw.2023.40039